Gardasil 9, Injektionssuspension in Fertigspritze
7680653870019
CH-65387
Injektionssuspension
Associated product:
GARDASIL 9 sol inj 30 µg 1 pce
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionssuspension
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
proteinum L1 papillomaviri humani typus 6
|
30.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum L1 papillomaviri humani typus 11
|
40.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum L1 papillomaviri humani typus 16
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum L1 papillomaviri humani typus 18
|
40.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum L1 papillomaviri humani typus 31
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum L1 papillomaviri humani typus 33
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum L1 papillomaviri humani typus 45
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum L1 papillomaviri humani typus 52
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum L1 papillomaviri humani typus 58
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
aluminium
|
- | Substance | HNIDK |
|
aluminii hydroxyphosphas sulfas amorphus
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
natrii boras
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
3.78 MG | Substance | HBESI |
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 65387
- Drug name
- Gardasil 9, Injektionssuspension in Fertigspritze
- Galenic form
- INJFS
- ATC Code
- J07BM03
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 29/07/2016
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- GARDASIL 9 sol inj 30 µg 1 pce
- Description (DE)
- GARDASIL 9 Inj Lös 30 µg 1 Stk
- Market launch
- 29/07/2016
- Narcotic (BTM)
- No
Other package sizes (1)
GARDASIL 9 sol inj 30 µg 10 pce
10 FESP
GTIN: 7680653870026